Malaka Ameratunga
@Mal_Ameratunga
Followers
79
Following
541
Media
1
Statuses
263
Lapidus et al. @Mal_Ameratunga conducted a Delphi study to establish consensus on assessing fitness to drive in brain tumor patients, highlighting the importance of stable imaging and continual reassessment as key evaluation factors. #JNO Read more: https://t.co/a9pVz34QwB
0
2
5
Thrilled that our collab with @Mal_Ameratunga @MonashUni on #drugrepurposing in oncology is out https://t.co/K6eebMeGBn 14% of cancer patients that currently have no treatment options could potentially benefit from drugs approved for other indications! @idibell_cat @ICO_oncologia
pubmed.ncbi.nlm.nih.gov
A computational drug repurposing approach may assist in identifying novel repurposing events in cancer patients with no access to standard therapies. Further validation is needed to confirm a...
2
2
13
1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now @LancetRespirMed - https://t.co/orK2owgN2T. Led by 🫁@DanSteinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc @tssmn @PeterMacRadOnc
17
108
272
This World Pharmacists’ Day, I want to say a massive thank you to all my pharmacist colleagues: we’re in difficult times, but I value working with you now more than ever! #WPD2020 (video was for @Austin_HealthRx, but for everyone! @AustPrescriber @the_shpa @PSA_National @psa_vic)
0
10
54
Pretty interesting if true.
1/ Severe COVID-19 in 2 families was associated with a rare loss of function mutation in TLR7. This Toll-like receptor helps activate the innate immune system to RNA viruses through cytokines and recruitment. Lots to think about and discuss... https://t.co/ql9kMHP7GP
0
0
1
POST-Covid19 RESET/REBOOT OF CANCER RESEARCH. Tweetorial for: https://t.co/7jDW66vtQI
@ICR_London @royalmarsdenNHS @CR_UK @ECMC_UK @cancerBRC @NIHRresearch
1
6
13
A model isn't very useful if it's not accurate. Below is my analysis on how various models considered by the CDC have performed over the past two weeks. https://t.co/WcXlfxv3Ah has consistently been the most accurate model thus far, for both US and state-by-state projections.
15
126
281
Informative thread on how the new COVIDSafe app works. If enough people download this app, it could improve & augment contact tracing in Australia. Whether or not to download it is up to you (I have) #COVID19
About how the Australian COVIDSafe app helps with contact tracing. A thread. This is from the perspective of an epidemiologist - I don't have any expertise on the technical or privacy aspects. https://t.co/JB4hhrB4x6
0
1
10
@CDunnart @AmyRemeikis Here's the full paper, just released by Doherty Inst:
0
2
3
At the @scalpcooling Booth helping them in supporting @ConquerCancerFd by sharing my selfie photo #PaxmanXConquerCancer $5 donated 👍🏿
1
10
18
Poster presentation of proteomic approaches to study drug resistance at AACR 2019 by Alex Georgiou, a talented clinical fellow who has finished training in my lab.
0
4
16
I wrote something about my time at Airbnb
marker.medium.com
Create strong culture, stay laser-focused on problems, and set wildly ambitious goals
48
225
1K
🤔 coffee enemas, saunas and laser therapies that she remortgaged her house to afford in Mexico or was it the ALK targeted therapy? ‘Terminally-ill British mother shocks medics after tumour shrinks 75% following alternative treatment in Mexico’
dailymail.co.uk
Kate Malvenan, 40, was given the cancer diagnosis in October last year where doctors told her she only had months left to live. She remortgaged her house to fund the £35,000 programme.
8
6
50
Dr Gamze Abali unravelling the intricacies of melanin pigment and melanoma heterogeneity at @LorneCancer
0
3
16
Dr Albert Antolin (@antolin_aa) is a Sir Henry Wellcome Postdoctoral Fellow in Systems Pharmacology - check out this fantastic interview about his career so far and why he thinks working here at the ICR is so special... #sciencecareers #postdoc #ICRjobs
0
4
11
"The off-target kinase landscape of clinical PARP inhibitors" is the #1 paper on bioRxiv today in pharmacology and toxicology. Congrats @antolin_aa @udai_banerji. See it at -> https://t.co/ABnUMecKqT and https://t.co/2erBtge8r8. Please retweet.
0
2
2
Did you know that our free @canSAR_ICR knowledgebase helps support translational cancer research and #drugdiscovery? https://t.co/PrpyWJ8Mw8
0
2
3
Are you interested in drug repurposing? This new review https://t.co/uJ0t8lAy98 describes strategies for drug repurposing and puts forward recommendations to advance the field
1
34
41
Alexandros Georgiou from @ICR_London and @royalmarsdenNHS presenting phosphoproteomic data related to KRAS mutant and wild type colorectal cancer at ESMO 2018. This translational research work will lead to hypothesis testing clinical trials through the @ECMC_UK and @cancerBRC
1
8
31
Definitive study on electrolyte abnormalities in phase I setting by @AlvarohiGarces. Hyponatraemia prognostic in addition to albumin and electrolyte abnormalities could be surrogates for gauging severity for GI toxicities AddThis | Home
0
0
4